leisure time -WSS

leisure time

author：entertainment 2025-09-27 10:01:57 - browse：1

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Young boy dies in trial for Pfizer Duchenne gene therapy

leisure time

WSS

Gut bacteria may contribute to kidney autoimmunity, study finds

Bird flu reported in person exposed to presumably infected cattle

Gut bacteria may contribute to kidney autoimmunity, study finds

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Pancreatic cancer is often deadly, but new discoveries are raising hope

AI can’t replace a physician’s gut feeling

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

Cancer drug shortages should be causing more outrage

People with mental disorders often marry others with same

Jerome Adams on the need for new antivirals for Covid

Group opposing PBM reform sets lobbying record

Cancer drug shortages should be causing more outrage

Scientific mystery highlights the blind spots in genomics databases

Sports medicine is finally prioritizing gender equality

Google and Epic fight stronger regulation of AI in health care

Medicare details structure of new drug price negotiation program

A public scorecard can help hold safety

explore

First Opinion on colorectal cancer screening: letter and response

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

How dance can help nurses traumatized by Covid

Researchers test human milk's ability to repair gut microbiome

FDA approves RSV monoclonal antibody for infants, toddlers

Pancreatic cancer is often deadly, but new discoveries are raising hope

focus

leisure time

focus

Wikipedia